Horizon Pharma reported $9.03B in Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
ALKERMES ALKS:US USD 1.94B 15.52M
Amgen AMGN:US USD 65.12B 1.42B
AstraZeneca AZN:LN USD 94.18B 2.39B
Cara Therapeutics CARA:US USD 213.51M 13.06M
Coherus Biosciences CHRS:US USD 550.91M 4.9M
Endo International Ordinary Shares ENDP:US USD 6.01B 355.8M
Horizon Pharma HZNP:US USD 9.03B 174.39M
JAZZ PHA JAZZ:US USD 10.38B 815.47M
Novartis NOVN:VX USD 118.46B 4.45B
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Perrigo Ordinary Shares PRGO:US USD 10.68B 242.1M
Prestige Brands PBH:US USD 3.75B 71.26M
Revance Therapeutics RVNC:US USD 711.59M 149.71M
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Takeda 4502:JP JPY 13.5T 1.08T
Teva Pharmaceutical Industries TEVA:US USD 44.25B 1.68B
Valeant Pharmaceuticals VRX:CN USD 26.3B 1.87B
Xeris Pharmaceuticals Inc XERS:US USD 303.02M 15.6M
Zoetis ZTS:US USD 13.67B 96M